Recombinant Comments : Analyzing the Public Response to Proposed rDna Products
Author(s)
Mabis, MatthewContributor(s)
Turner, Stephanie S.Keywords
Genetic engineering--Moral and ethical aspectsScience and state--Citizen participation
Technology and state--Citizen participation
Posters
Full record
Show full item recordOnline Access
http://digital.library.wisc.edu/1793/54803Abstract
Color poster with text, charts, and graphs.A significant issue in the public understanding of science is the way in which citizens use digital media to influence policy making on cutting-edge research and emerging technologies. This study examines the public comments on the Food and Drug Administration's proposed guidelines for ATryn, the first drug manufactured from nonbacterial recombinant DNA, that is, human-animal gene splicing.
University of Wisconsin--Eau Claire Office of Research and Sponsored Programs
Date
2011-11-01Type
PresentationIdentifier
oai:minds.wisconsin.edu:1793/54803http://digital.library.wisc.edu/1793/54803